why choose us

First received: December 21, 2022

Clinical Trial: Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Relapsed and Refractory Multiple Myeloma (RRMM)

Study Type: OBSERVATIONAL


Official Title: A Study to Characterize Treatment Patterns and Real-World Outcomes in Heavily Pretreated Patients With Relapsed and Refractory Multiple Myeloma (RRMM) and Similar Clinical Characteristics to Patients

Brief Summary: Primary Objective:1. To describe the distribution of treatment regimens and objective response rate (ORR) in a Benchmark Cohort of real-world patients with relapsed/refractory multiple myeloma (RRMM) who initiate treatment after meeting the following criteria: (1) have either (a) at least three prior lines (3L) and are triple-class exposed (TCE), or (b) are triple-class refractory (TCR), and (2) meet similar inclusion/exclusion criteria to patients in phase 2 cohort 2 of the R5458-ONC-1826 (NCT03761108)…

Read more